Literature DB >> 1970488

Serum levels of tumor necrosis factor alpha in patients treated with granulocyte-macrophage colony-stimulating factor.

B Stehle, C Weiss, A D Ho, W Hunstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970488

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

2.  Effects of granulocyte and granulocyte-macrophage colony-stimulating factors in a neutropenic murine model of trichosporonosis.

Authors:  H Muranaka; M Suga; K Nakagawa; K Sato; Y Gushima; M Ando
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

3.  Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice.

Authors:  G Tiegs; J Barsig; B Matiba; S Uhlig; A Wendel
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 4.  New modalities for treating neonatal infection.

Authors:  A R Bedford-Russell
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

5.  Granulocyte and granulocyte-macrophage colony-stimulating factors exert differential effects on neutrophil platelet-activating factor generation and release.

Authors:  A G Stewart; T Cotterill; T Harris
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

Review 6.  Drug-induced thrombosis: an update.

Authors:  Yuval Ramot; Abraham Nyska; Galia Spectre
Journal:  Drug Saf       Date:  2013-08       Impact factor: 5.606

7.  Continuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: increased efficacy and reduced toxicity when given subcutaneously.

Authors:  A H Honkoop; K Hoekman; J Wagstaff; C J van Groeningen; J B Vermorken; E Boven; H M Pinedo
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.